Neurology Archives | Page 2 of 7

Publishing their work in the Proceedings of the National Academy of Sciences, Vibhor Krishna, MD, at the UNC School of Medicine, and colleagues discovered that specific neurons in the brain are actively involved in processing cardiac and respiratory signals.

Under the direction of assistant professor of radiology Li-Ming Hsu, the research demonstrates how long-term cocaine use affects brain functions, making recovery and stifling cravings more difficult.

David Y. Hwang, MD, professor of neurology and division chief of neurocritical care, is co-principal investigator along with colleagues at Duke for a new eastern North Carolina and southern Virginia stroke clinical trial coordinating center.

UNC Health is the only academic healthcare system in North Carolina and the South participating in the randomized trial, which aims to assess the safety and efficacy of a combination immunotherapy for newly diagnosed glioblastoma patients.

James F. Howard, MD, Distinguished Professor of Neuromuscular Disease, Professor of Neurology, Medicine and Allied Health at the UNC School of Medicine, was the lead investigator of the clinical trial.

A $100,000 grant from the Neurocritical Care Foundation has been awarded to David Y. Hwang MD, division chief of neurocritical care in the Department of Neurology at the UNC School of Medicine, and colleagues to research an intervention to support family caregivers of patients surviving ICU admission for coma.

Miriam Sklerov, MD, of the UNC Neurology Movement Disorders Center, recently won a National Institutes of Mental Health K23 award for her project, "Investigation of non-invasive brain stimulation for the treatment of apathy."

UNC Neurology researcher Ian Shih has received a $2.4 million NIH grant to improve functional brain imaging techniques.

A $100,000 grant from the Neurocritical Care Foundation has been awarded to David Y. Hwang MD, FAAN, FCCM, FNCS, division chief of neurocritical care in the Department of Neurology at the UNC School of Medicine, and colleagues to research an intervention to support family caregivers of patients surviving ICU admission for coma.

Published in The Lancet Neurology, a study led by James Howard, MD, professor of neurology at the UNC School of Medicine, showed how an RNA CAR-T therapy developed by Cartesian Therapeutics can dramatically improve symptoms in patients with myasthenia gravis, an autoimmune disorder.

James Howard, MD, professor of neurology at the UNC School of Medicine, was the principal investigator of the RAISE clinical trial of zilucoplan, one of two drugs under regulatory review to treat myasthenia gravis.

Dominique Higgins, MD, PhD, led research into how a specialized diet can induce a new type of programmed cell death to help kill brain tumor cells.

Category: Neurology

Researchers Expand Our Understanding of How the Body and Brain Communicate

Research Shows Continued Cocaine Use Disrupts Communication Between Major Brain Networks

UNC Neurology Joins NIH StrokeNet Clinical Trials Network

New, Promising Clinical Trial for Glioblastoma Starting at UNC Health

Zilucoplan Approved by FDA for Treatment of Generalized Myasthenia Gravis in Adults

Hwang Receives Grant to Study Emotional Support Intervention for Caregivers of Patients Surviving ICU Admission for Coma

Sklerov Receives NIMH Award to Investigate Treatment for Apathy

Neurology Receives Funding to Develop New Brain Imaging Method

Hwang Receives Grant to Study Emotional Support Intervention for Caregivers of Patients Surviving ICU Admission for Coma

Howard Leads First Successful Clinical Trial of RNA Cell Therapy in Autoimmune Disease

Rozanolixizumab, Zilucoplan Phase 3 Generalized Myasthenia Gravis Study Results Published in The Lancet Neurology

Researchers Leverage Cell Self-Destruction to Treat Brain Tumors